We are live on ! Find out more
HI

HBK Investments Portfolio holdings

AUM $9.85B
1-Year Est. Return 55.6%
This Fund
S&P 500
This Quarter Est. Return
+22.68%
1 Year Est. Return
+55.6%
3 Year Est. Return
+156.38%
5 Year Est. Return
+423.64%
10 Year Est. Return
+2,347.17%
AUM
$15.3B
AUM Growth
+$1.92B
Cap. Flow
-$855M
Cap. Flow %
-5.58%
Top 10 Hldgs %
58.72%
Holding
844
New
214
Increased
88
Reduced
167
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 5.17%
2 Healthcare 2.88%
3 Consumer Discretionary 2.31%
4 Financials 2.07%
5 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
126
PUT
Mastercard
MA
$493B
$8.1M 0.05%
22,700
+21,800
+2,422% +$7.25M
RKLB icon
127
Rocket Lab Corp
RKLB
$51.8B
$8.06M 0.05%
+797,301
New +$8.13M
CAT icon
128
CALL
Caterpillar
CAT
$387B
$8.03M 0.05%
44,100
-8,000
-15% -$1.36M
CVS icon
129
CVS Health
CVS
$122B
$8.03M 0.05%
117,500
-25,625
-18% -$1.67M
EVGO icon
130
EVgo
EVGO
$229M
$8.01M 0.05%
+747,400
New +$7.72M
ELV icon
131
Elevance Health
ELV
$85.5B
$8M 0.05%
+24,927
New +$7.65M
M icon
132
PUT
Macy's
M
$6.68B
$7.98M 0.05%
709,200
ATIP
133
DELISTED
ATI Physical Therapy, Inc.
ATIP
$7.98M 0.05%
+14,866
New +$7.5M
XOM icon
134
CALL
ExxonMobil
XOM
$634B
$7.92M 0.05%
192,100
-34,000
-15% -$1.27M
SKIN icon
135
SkinHealth Systems
SKIN
$85.7M
$7.92M 0.05%
+700,000
New +$7.53M
M icon
136
Macy's
M
$6.68B
$7.91M 0.05%
703,223
+21,755
+3% +$186K
TSIAU
137
DELISTED
TS Innovation Acquisitions Corp. Unit
TSIAU
$7.91M 0.05%
+750,000
New +$7.63M
ME
138
DELISTED
23andMe Holding Co
ME
$7.9M 0.05%
+34,540
New +$7.73M
MSFT icon
139
Microsoft
MSFT
$3.71T
$7.86M 0.05%
35,358
+499
+1% +$107K
OACB
140
DELISTED
Oaktree Acquisition Corp. II
OACB
$7.86M 0.05%
+749,500
New +$7.6M
BKSY icon
141
BlackSky Technology
BKSY
$1.19B
$7.85M 0.05%
93,750
CORT icon
142
PUT
Corcept Therapeutics
CORT
$12B
$7.85M 0.05%
300,000
CONXU
143
DELISTED
CONX Corp. Unit
CONXU
$7.84M 0.05%
+750,000
New +$7.61M
PCPC.U
144
DELISTED
Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
PCPC.U
$7.83M 0.05%
+300,000
New +$7.7M
PDAC
145
DELISTED
Peridot Acquisition Corp.
PDAC
$7.77M 0.05%
+750,000
New +$7.51M
FPAC.U
146
DELISTED
Far Peak Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
FPAC.U
$7.76M 0.05%
+750,000
New +$7.67M
GS icon
147
CALL
Goldman Sachs
GS
$303B
$7.75M 0.05%
29,400
-5,800
-16% -$1.29M
MDLA
148
PUT
DELISTED
Medallia, Inc.
MDLA
$7.73M 0.05%
232,800
+55,400
+31% +$1.77M
HAACU
149
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
$7.71M 0.05%
+700,000
New +$7.59M
CTAQU
150
DELISTED
Carney Technology Acquisition Corp. II Units
CTAQU
$7.7M 0.05%
+750,000
New +$7.7M

Similar funds

HBK Investments's Q4 2020 Portfolio in Review

As of Q4 2020, HBK Investments held 844 positions worth $15.3B, up 14% from $13.4B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

HBK Investments withdrew a net $855M in Q4 2020, closing 165 positions and reducing 167 holdings. Its most notable exit was Immunomedics Inc, an estimated $553M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, HBK Investments opened a new position in Slack Technologies, Inc. worth $607M.

  • HBK Investments's largest Q4 2020 buy was Slack Technologies, Inc.: 14,369,573 shares worth $607M.
  • HBK Investments added most to Maxim Integrated Products in Q4 2020, an estimated $287M increase.
  • HBK Investments's biggest Q4 2020 reduction was Broadcom, cutting an estimated $16.2M.
  • HBK Investments fully exited Immunomedics Inc in Q4 2020, selling an estimated $553M.
  • HBK Investments's ten largest holdings make up 59% of its $15.3B portfolio in Q4 2020.
  • HBK Investments opened 214 new positions and closed 165 in Q4 2020.
  • HBK Investments's portfolio value rose 14% quarter-over-quarter to $15.3B.

Based on HBK Investments's 13F filing for Q4 2020, filed 16 Feb 2021.